Stock TVGN TEVOGEN BIO HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tevogen Bio Holdings Inc.

Equities

TVGN

US88165K1016

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
0.82 USD -7.87% Intraday chart for Tevogen Bio Holdings Inc. -16.71% -92.63%
May. 13 Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday MT
May. 13 Top Premarket Gainers MT

Business Summary

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, is an off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy designed to fill a critical gap in COVID-19 therapeutic solutions for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of Long COVID. In addition to TVGN 489, it has several product candidates under early-stage development. The Company is developing Epstein-Barr virus (EBV) specific CTLs for potential use in multiple sclerosis (MS) and EBV-associated lymphomas. Its TVGN 601 is being developed for MS, and its TVGN 930 is being developed for EBV-associated lymphomas.

Number of employees: 19

Members of the board

Members of the board TitleAgeSince

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 164,614,418 5,577,718 ( 3.388 %) 0 3.388 %

Shareholders

NameEquities%Valuation
Ryan Saadi
71.95 %
118,443,975 71.95 % 101 M $
Semper Paratus Sponsor LLC
8.069 %
13,283,333 8.069 % 11 M $
Kirti Desai
5.890 %
9,696,186 5.890 % 8 M $
Portland Global Advisors LLC
3.513 %
5,782,209 3.513 % 5 M $
Neal Flomenberg
3.240 %
5,332,902 3.240 % 5 M $
Sadiq Khan
0.5890 %
969,618 0.5890 % 824 175 $
Curtis Patton
0.5890 %
969,618 0.5890 % 824 175 $
Harraden Circle Investments LLC
0.5097 %
838,971 0.5097 % 713 125 $
Jeffrey Feike
0.3534 %
581,771 0.3534 % 494 505 $
Polar Asset Management Partners, Inc.
0.2033 %
334,615 0.2033 % 284 423 $
NameEquities%Valuation
Parallax Volatility Advisers LP
-
2,846,205 - 156 541 $
Highbridge Capital Management LLC
-
1,917,178 - 105 445 $
FourWorld Capital Management LLC
-
1,450,000 - 79 750 $
Corbin Capital Partners LP
-
1,160,000 - 63 800 $
Calamos Advisors LLC
-
1,000,000 - 55 000 $
Cantor Fitzgerald & Co.
-
910,500 - 50 078 $
Polar Asset Management Partners, Inc.
-
717,307 - 39 452 $
MMCAP International Inc. SPC
-
650,000 - 35 750 $
Linden Advisors LP
-
649,999 - 35 750 $
Periscope Capital, Inc.
-
608,900 - 33 490 $

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
TEVOGEN BIO HOLDINGS INC. Stock Tevogen Bio Holdings Inc.
-92.63% 135M
MODERNA, INC. Stock Moderna, Inc.
+33.63% 50.93B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.09% 42.12B
LONZA GROUP AG Stock Lonza Group AG
+49.62% 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
-4.96% 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.18% 26.02B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.95% 18.9B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.61% 13.21B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.73% 12.17B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.31% 12.16B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. TVGN Stock
  4. Company Tevogen Bio Holdings Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW